The HbA1c Testing Devices Market was valued at USD 1.72 billion in 2023 and is expected to reach USD
This report underscores the increasing prevalence and incidence of diabetes, fueling demand for HbA1c testing as a key measure for assessing long-term blood glucose control. The study discusses regulatory and reimbursement trends, looking at how government policy, insurance coverage, and healthcare funding influence market accessibility and adoption. Further, it discusses technological progress in HbA1c testing instruments, such as a transition towards point-of-care and continuous glucose monitoring for enhanced convenience to patients. The report further analyzes healthcare expenditures on diabetes control and HbA1c testing in various regions, accounting for the government, commercial, private, and out-of-pocket expenditures in dictating market expansion.